Timken Q2 Earnings Hit by $88M in Impairment Charges; Adjusted EPS Beats, Full-Year Guidance Raised
TKR sits 87% above its 52-week low of $70.565 on elevated volume (2.3× avg).
Summary
Timken reported Q2 GAAP EPS of $0.41, down sharply on $87.9M in impairment charges, but adjusted EPS of $1.83 beat expectations and full-year guidance was raised. The company is reshaping its portfolio with the Bijur Delimon acquisition and the planned sale of its belts business.
Key Events · Earnings and Guidance · TKR
-
Q2 GAAP EPS Plunges on Impairments
Net income attributable to Timken fell to $28.9M ($0.41 diluted EPS) from $78.5M ($1.12) a year ago, driven by $87.9M in impairment and restructuring charges, primarily from the belts divestiture and Springfield plant closure.
-
Adjusted EPS Beats, Guidance Raised
Adjusted EPS of $1.83 for Q2 2026 exceeded the prior-year $1.42. Full-year 2026 revenue growth is now expected at 5-6%, with adjusted EPS guidance raised, though GAAP earnings will be down slightly due to impairment charges.
-
Belts Business Divestiture and Plant Closure
Timken entered a definitive agreement to sell its belts business to Gates, recording a $64.4M impairment. The Springfield, MO belts facility will close, adding $14.6M in impairment and $2.7M in severance. Total pretax costs for these actions are estimated at $100M-$108M.
-
Bijur Delimon Acquisition Closed
The $124.4M acquisition of Bijur Delimon, a global automated lubrication systems maker, was completed in March 2026, adding $52M in goodwill and expanding the Industrial Motion segment.
Analysis · TKR · Technology
Timken's Q2 GAAP earnings were crushed by $87.9 million in impairment and restructuring charges tied to the planned sale of its belts business and a plant closure. Stripping those out, adjusted EPS of $1.83 handily beat the $1.42 from a year ago, and the company raised its full-year adjusted EPS guidance. The quarter also saw the acquisition of Bijur Delimon and a new $1.2 billion credit facility that extends maturities to 2031. The belts divestiture, expected to close in Q3, will remove an underperforming asset but comes with a painful $64.4 million write-down. The market will focus on the strong underlying operations and the strategic reshaping of the portfolio.
At the time of this filing, TKR was trading at $132.03 on NYSE in the Technology sector, with a market capitalization of approximately $9.2B. The 52-week trading range was $70.57 to $146.37. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.